DESFERAL Sterile, lyophilised powder

Active ingredients: Deferoxamine

Product name and form

Desferal Vials, 500mg or 2g.

Pharmaceutical Form

A sterile, lyophilised powder available in vials containing 500mg or 2g of desferrioxamine mesilate.

Qualitative and quantitative composition

Each vial contains desferrioxamine mesilate 500mg or 2g.

Active Ingredient
Description
Deferoxamine

Deferoxamine is a chelating agent for trivalent iron and aluminium ions. The resulting chelates are stable and non-toxic.

List of Excipients

None present.

Pack sizes and marketing

Each vial contains a white to practically white lyophilisate supplied in a clear glass vial in a pack size of 10 (500 mg) or 1 (2 g).

Marketing authorization holder

Novartis Pharmaceuticals UK Limited

Trading as: Ciba Laboratories, Frimley Business Park, Frimley, Camberley, Surrey, GU16 7SR

Marketing authorization dates and numbers

PL 00101/0523

31 October 1997 / 12 December 2000

Drugs

Drug
Countries
DESFERAL
Austria, Brazil, Canada, Cyprus, Finland, France, Hong Kong, Ireland, Italy, Lithuania, Netherlands, Poland, Tunisia, United Kingdom, United States
Next: Usage